Laddar...
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
Familial hypercholesterolemia (FH) is the most common inherited form of dyslipidemia and a major cause of premature cardiovascular disease. Management of FH mainly relies on the efficiency of treatments that reduce plasma low-density lipoprotein (LDL) cholesterol (LDL-C) concentrations. MicroRNAs (m...
Sparad:
| I publikationen: | Clin Rev Allergy Immunol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer US
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874276/ https://ncbi.nlm.nih.gov/pubmed/28534160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12016-017-8611-x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|